What makes ibogaine different from EMDR or other trauma therapies?

EMDR, CPT, and somatic approaches work within ordinary states of consciousness, session by session, building new associations gradually. Ibogaine produces a 12–24 hour window of heightened neuroplasticity — driven by rapid increases in GDNF and BDNF — during which the brain processes traumatic memory with reduced emotional reactivity. The Stanford study found 88% average reduction in PTSD symptoms at one month in combat veterans. That is not a claim that ibogaine replaces trauma therapy. For many people, prior therapeutic work makes ibogaine more effective — it builds the framework needed to integrate what surfaces during the experience.

Who is not an appropriate candidate for ibogaine trauma treatment?

Absolute contraindications regardless of trauma history: QT prolongation or significant cardiac arrhythmia; current SSRIs or SNRIs (a supervised taper must be completed first — there are no exceptions); lithium; methadone without a completed transition protocol; severe liver or kidney disease; active psychosis or schizophrenia-spectrum disorder; and pregnancy. Acute psychiatric crisis is also a disqualifier — ibogaine surfaces and amplifies what is present, which is not appropriate for someone who is currently destabilised.

What is the ibogaine experience like for someone with a trauma history?

The active experience runs 12–24 hours. For many people with trauma, the most common report is a structured review of personal history — autobiographical memories surfacing with unusual clarity and reduced emotional reactivity. The material that surfaces is not chosen. The medicine does not allow avoidance of what is present. This is distinct from conventional psychedelic experiences in that it tends to be narrative rather than perceptual — less visual, more like watching the past unfold. The days after ceremony are typically marked by fatigue and emotional openness. The recovery period is 2–3 days.

How long do ibogaine's effects on trauma last?

The Stanford study measured outcomes at one month post-treatment: 88% average reduction in PTSD symptoms, 87% in depression symptoms, 81% in anxiety symptoms. Noribogaine, ibogaine's active metabolite, remains active in the body for weeks to months after ceremony and appears to sustain a neuroplasticity window during that period. Whether the gains at one month persist long-term depends substantially on what happens during integration — the structured work in the weeks following ceremony that consolidates what opened during the experience.

Does prior trauma therapy help prepare someone for ibogaine ceremony?

Generally yes. Prior therapeutic work builds a framework for integrating what surfaces during ceremony — someone who understands their trauma history intellectually is better positioned to work with the material when it appears. This does not mean conventional therapy must be exhausted first. It means that ibogaine is not a substitute for the work of integration, and people who have done some of that work tend to get more from the experience than people who arrive without context for what surfaces.

Is ibogaine or 5-MeO-DMT more appropriate for trauma?

They work on different layers. Ibogaine tends to produce an autobiographical review — confrontation with specific memories, events, and the emotional content attached to them. 5-MeO-DMT tends to produce a dissolution of the sense of self, with less narrative content. For trauma that is anchored to specific memories and events, ibogaine is typically the primary consideration. For someone who has already done significant processing of the narrative and is working on the deeper structural sense of self, 5-MeO-DMT may be more relevant. The contraindications for SSRIs and SNRIs are identical for both medicines.

What does ibogaine trauma treatment cost in Canada?

Iboga ceremony at a legitimate Canadian programme costs $2,000–$5,000 CAD. This covers an on-site physician throughout the 12–24 hour active experience, continuous cardiac monitoring, the whole-plant root bark, facilitation, and 2–3 days of supervised recovery. Integration coaching — $150–$300 CAD per session, with packages of three or more sessions available — is separate. Providers operating significantly below this range have typically removed the medical infrastructure that makes iboga ceremony safe.

Is ibogaine for trauma legal in Canada?

Iboga root bark is not listed under Canada's Controlled Drugs and Substances Act. It is not approved for medical use, but it is not explicitly prohibited — a legally distinct situation from the US Schedule I classification or the UK Class A classification. This allows providers to operate openly with full medical infrastructure: on-site physicians, cardiac monitoring, blood panels — the components that make ceremony safe and that providers in more legally restrictive markets have incentives to reduce or eliminate.

Ibogaine for Trauma: What the Evidence Shows and Who It Is Not For

Ibogaine's most documented effect on trauma came from a 2023 Stanford study published in Nature Medicine: 30 special operations veterans with PTSD, traumatic brain injury, and treatment-resistant depression showed an average 88% reduction in PTSD symptoms one month after a single ibogaine session. That population was combat veterans. The mechanism is not specific to combat.

What ibogaine appears to do for trauma: It produces a period of heightened neuroplasticity — driven by increases in GDNF and BDNF — during which the brain processes autobiographical memory differently than it does in ordinary waking life. Traumatic memories surface with reduced emotional reactivity. The experience does not erase the memory. It changes the relationship to it. That window closes within 12–24 hours. What happens with the material during that window, and in the weeks after, determines what persists.

How Ibogaine Acts on Traumatic Memory

Three mechanisms are relevant here, and they operate simultaneously during a ceremony.

Neuroplasticity. Ibogaine produces a rapid increase in glial cell line-derived neurotrophic factor (GDNF) and brain-derived neurotrophic factor (BDNF). These are the proteins responsible for neuronal repair and the formation of new synaptic connections. The result is a window — lasting roughly the 12–24 hours of the active experience — in which the brain is more capable of forming and revising learned associations than it normally is. Trauma is encoded as a learned association. This window is when the work happens.

NMDA receptor antagonism. Ibogaine acts as an NMDA receptor antagonist, which disrupts the normal consolidation of memory during the experience. This is part of why memories that surface during ibogaine ceremony have a different quality — they are accessible without triggering the same physiological fear response that makes trauma therapy slow and difficult in ordinary states.

Autobiographical review. The phenomenology of iboga ceremony — what people actually report experiencing — frequently involves a structured review of the personal past. Not hallucination in the conventional sense. More like watching your own life with unusual clarity and reduced emotional reactivity. The medicine does not accommodate avoidance. Material surfaces whether a person is trying to confront it or not.

PTSD vs Complex Trauma — What the Research Actually Covers

The Stanford population was specific: veterans with combat-related PTSD, traumatic brain injury, and treatment-resistant depression. Single-incident trauma with a clear onset. The DSM-5 diagnostic criteria for PTSD were developed primarily around this kind of event.

Complex PTSD — or developmental trauma — is different. It arises from repeated, prolonged traumatisation, often in childhood, often at the hands of caregivers. The presentations are different: pervasive affect dysregulation, chronic shame, relational disruption, difficulty constructing a coherent self-narrative. The neurological signature overlaps with single-incident PTSD in some respects and diverges in others.

There are no randomised controlled trials of ibogaine specifically in C-PTSD populations. The mechanistic case for ibogaine working on complex trauma is plausible — GDNF/BDNF increases do not distinguish between trauma types, and the autobiographical review process can surface developmental material as readily as combat material. But plausible is not the same as tested. The integration demands after ibogaine ceremony are substantial for anyone. For someone with complex trauma, they may be more substantial still. That needs to be part of the conversation before ceremony.

What the Evidence Shows

The Stanford study — Cherian et al., Nature Medicine, February 2023 — is the most rigorous data currently available. The headline numbers at one month post-treatment:

PTSD symptoms: 88% average reduction
Depression symptoms: 87% average reduction
Anxiety symptoms: 81% average reduction

Context matters here. The sample was 30 people, all male, all special operations veterans, all treated at a single site in Mexico. There was no placebo control — a blinded placebo design for a 12–24 hour psychedelic experience is methodologically difficult. The research team was not blind to treatment status. These are real limitations that do not erase the findings, but they do qualify them.

For comparison: in conventional antidepressant research, a 50% reduction in depression scores is considered a strong response. The ibogaine numbers in the Stanford study are not a rounding error above that benchmark.

Texas committed $50 million to clinical ibogaine trials through UTMB, UTHealth Houston, Texas A&M, and Baylor University following the Stanford publication. The Multidisciplinary Association for Psychedelic Studies maintains a running review of the clinical literature. The field is active. The data from current trials will be more robust than what Stanford produced, because those trials are designed with the limitations in mind.

Who Tends to Benefit

The people who get the most from ibogaine ceremony for trauma are generally not the people who arrive most optimistic about it.

One pattern that shows up consistently: someone who has spent years in conventional treatment — therapy, medication, sometimes inpatient programmes — and has made real progress, but remains stuck at a particular floor. They have done the work. They know the material intellectually. The problem is not insight. The problem is that the insight has not reached the part of the nervous system where the trauma lives. They arrive sceptical, because they have been disappointed before. The medicine does not seem to care about the scepticism.

What seems to predict benefit: genuine readiness for what surfaces — not enthusiasm, not courage, but a settled willingness to see the material clearly. Prior therapeutic work tends to help because it builds a framework for integrating what comes up. A support system that continues after ceremony is not optional — it determines whether what opens during the experience closes into something useful or stays raw.

What Ibogaine Does Not Do

Ibogaine is not a cure for trauma. The 88% reduction in PTSD symptoms at one month is a compelling number. It is not a guarantee, it is not permanent without integration, and it is not what everyone who attends ceremony experiences.

Integration support is not a bonus service — it determines whether the ceremony produces lasting change. The neuroplasticity window opens during the experience. What gets consolidated into new patterns during the weeks that follow depends entirely on what a person does with that window. Ibogaine without a plan for the integration period is like having the conversation and never doing anything with what you learned. Some people find the experience profound and still return to baseline within weeks. The medicine did not fail them. The integration did.

Ibogaine is also not a first-line treatment. It carries real medical risk, requires real preparation, and produces a 12–24 hour experience that demands genuine readiness. Conventional treatments — EMDR, CPT, medication, standard-of-care PTSD programmes — should be part of a person's history before ibogaine is appropriate to consider. Not because they work as well, but because they rule out whether a simpler option was sufficient, and because they often build the foundation that makes ibogaine more effective when it is used.

For more on what lasting benefit actually requires, the integration post covers what that period involves and what tends to determine whether ceremony results hold.

Who Is Not an Appropriate Candidate

The disqualifiers for ibogaine ceremony are the same regardless of what brought someone to consider it. A trauma history does not change the cardiac pharmacology.

QT prolongation or significant cardiac arrhythmia. Ibogaine extends the cardiac QT interval. For someone with a pre-existing prolongation or arrhythmia, this is the mechanism behind ibogaine-related deaths. A 12-lead EKG is required before any ceremony date is confirmed.
Current SSRIs or SNRIs. Absolute contraindication. A supervised taper must be completed and confirmed before the conversation about ceremony can progress. The risk of serotonin syndrome is real and potentially fatal. There are no case exceptions.
Lithium.Contraindicated. The interaction with ibogaine's cardiac effects is not a risk worth taking.
Methadone. Not a permanent disqualification, but a specific transition protocol to a shorter-acting opioid is required first. The timeline for this is weeks to months, depending on the dose. This is a preparation requirement, not a reason not to have the conversation.
Severe liver or kidney disease. Ibogaine is metabolised by the liver into noribogaine, which is renally cleared. Impaired function in either organ changes the pharmacokinetics in ways that are not predictable and not safe to ignore.
Active psychosis or schizophrenia-spectrum disorder. Ibogaine is contraindicated. The mechanism that produces autobiographical review in a neurotypical person produces an unpredictable and potentially harmful experience in someone with active psychotic processes.
Pregnancy. Contraindicated without exception.

Acute psychiatric crisis is not the right time for ceremony. Ibogaine works with what is present — it surfaces material and amplifies it. Someone in active crisis needs stabilisation first. A person who arrives in crisis is not an appropriate candidate regardless of what else might be true about them.

The contraindications post covers the full medical picture, including which disqualifiers are permanent and which require preparation timelines.

Is This Right for You

The most important step before considering ceremony is a conversation about medications. If you are currently on SSRIs, SNRIs, lithium, or methadone, that conversation determines what the preparation timeline looks like — and whether ceremony is medically accessible at all. That conversation happens with the prescribing physician, not with us, but it needs to happen before anything else.

The ceremony page covers what to expect before, during, and after — the medical screening process, the 12–24 hour active experience, and the 2–3 day recovery period that follows. The FAQ covers candidacy, medications, and the intake process directly. For a broader overview of ibogaine and 5-MeO-DMT together, this post covers how the two medicines compare and when one or both might be appropriate.

To start the conversation, reach out to jake.nylund@gmail.com. Every application receives a personal response within 2–3 business days.